bupropion hydrochloride
Generic: bupropion hydrochloride
Labeler: asclemed usa, inc.Drug Facts
Product Profile
Brand Name
bupropion hydrochloride
Generic Name
bupropion hydrochloride
Labeler
asclemed usa, inc.
Dosage Form
TABLET, EXTENDED RELEASE
Routes
Active Ingredients
bupropion hydrochloride 300 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
76420-812
Product ID
76420-812_2dffd9ed-8b4a-a56b-e063-6394a90ae043
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA077285
Listing Expiration
2026-12-31
Marketing Start
2015-02-17
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
76420812
Hyphenated Format
76420-812
Supplemental Identifiers
RxCUI
UNII
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
bupropion hydrochloride (source: ndc)
Generic Name
bupropion hydrochloride (source: ndc)
Application Number
ANDA077285 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 300 mg/1
Packaging
- 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (76420-812-01)
- 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (76420-812-05)
- 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (76420-812-30)
- 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (76420-812-60)
- 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (76420-812-90)
Packages (5)
76420-812-01
100 TABLET, EXTENDED RELEASE in 1 BOTTLE (76420-812-01)
76420-812-05
500 TABLET, EXTENDED RELEASE in 1 BOTTLE (76420-812-05)
76420-812-30
30 TABLET, EXTENDED RELEASE in 1 BOTTLE (76420-812-30)
76420-812-60
60 TABLET, EXTENDED RELEASE in 1 BOTTLE (76420-812-60)
76420-812-90
90 TABLET, EXTENDED RELEASE in 1 BOTTLE (76420-812-90)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "2dffd9ed-8b4a-a56b-e063-6394a90ae043", "openfda": {"unii": ["ZG7E5POY8O"], "rxcui": ["993557"], "spl_set_id": ["637e89e5-8f6e-4392-8045-a778cb9ed138"], "manufacturer_name": ["Asclemed USA, Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET, EXTENDED RELEASE in 1 BOTTLE (76420-812-01)", "package_ndc": "76420-812-01", "marketing_start_date": "20240507"}, {"sample": false, "description": "500 TABLET, EXTENDED RELEASE in 1 BOTTLE (76420-812-05)", "package_ndc": "76420-812-05", "marketing_start_date": "20240507"}, {"sample": false, "description": "30 TABLET, EXTENDED RELEASE in 1 BOTTLE (76420-812-30)", "package_ndc": "76420-812-30", "marketing_start_date": "20240507"}, {"sample": false, "description": "60 TABLET, EXTENDED RELEASE in 1 BOTTLE (76420-812-60)", "package_ndc": "76420-812-60", "marketing_start_date": "20240507"}, {"sample": false, "description": "90 TABLET, EXTENDED RELEASE in 1 BOTTLE (76420-812-90)", "package_ndc": "76420-812-90", "marketing_start_date": "20240507"}], "brand_name": "Bupropion Hydrochloride", "product_id": "76420-812_2dffd9ed-8b4a-a56b-e063-6394a90ae043", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Aminoketone [EPC]", "Dopamine Uptake Inhibitors [MoA]", "Increased Dopamine Activity [PE]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Uptake Inhibitors [MoA]"], "product_ndc": "76420-812", "generic_name": "Bupropion Hydrochloride", "labeler_name": "Asclemed USA, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Bupropion Hydrochloride", "active_ingredients": [{"name": "BUPROPION HYDROCHLORIDE", "strength": "300 mg/1"}], "application_number": "ANDA077285", "marketing_category": "ANDA", "marketing_start_date": "20150217", "listing_expiration_date": "20261231"}